The European Neoantigen Summit is the dedicated end-to-end meeting focused on challenges such as identifying immunogenic neoantigens, overcoming tumour heterogeneity, and improving the delivery modality of personalized neoantigen-based immunotherapeutic.
Hear the latest updates from pioneers in this field and define your commercialisation roadmap to achieve future regulatory success, scale manufacturing and ensure the safety profiles of your neoantigen therapy. As the field grows and seeks to demonstrate significantly improved clinical efficacy, join the key stakeholders to make the scientific, clinical and commercial decisions for therapeutic success.
"This meeting was the most comprehensive survey of the emerging field of neoantigen-based therapeutics with excellent speakers." - Argos Therapeutics